Literature DB >> 3131277

C4 allotyping on plasma or serum: application to routine laboratories.

W J Zhang1, P H Kay, T J Cobain, R L Dawkins.   

Abstract

Allotypes of the fourth component of complement (C4) can be detected by electrophoresis and immunofixation after treatment of EDTA plasma with neuraminidase (NAse). We have assessed the value of additional treatment with carboxypeptidase B (CPseB). Following treatment with CPseB + NAse, each allele is resolved into a single band, permitting clear definition of overlapping bands seen following treatment with NAse alone. More importantly, C4 allotypes can be determined using stored heparinized plasma or serum. Most C4 null alleles can be assigned without requiring family studies. The approach described is suitable for routine use by tissue typing laboratories.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131277     DOI: 10.1016/0198-8859(88)90068-7

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  12 in total

1.  Alloreactivity and association of human natural killer cells with the major histocompatibility complex.

Authors:  E Mavoungou; A Sall; V Poaty-Mavoungou; F S Toure; P Yaba; A Delicat; J Lansoud-Soukate
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Circulating immune complexes and complement C4 null alleles in patients in patients operated on for premature atherosclerotic peripheral vascular disease.

Authors:  S Nityanand; L Truedsson; A Mustafa; C Bergmark; A K Lefvert
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

3.  The genomic structure of two ancestral haplotypes carrying C4A duplications.

Authors:  K Tokunaga; W J Zhang; F T Christiansen; R L Dawkins
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

4.  Prolonged clinically asymptomatic evolution after HIV-1 infection is marked by the absence of complement C4 null alleles at the MHC.

Authors:  F Hentges; A Hoffmann; F Oliveira de Araujo; R Hemmer
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

5.  Usefulness of densitometry in typing of human complement component C4.

Authors:  J Kramer; E Gyódi; G Füst
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

6.  HLA associations with inclusion body myositis.

Authors:  M J Garlepp; B Laing; P J Zilko; W Ollier; F L Mastaglia
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

7.  Organization and evolution of C4 and CYP21 genes in primates: importance of genomic segments.

Authors:  W J Zhang; F T Christiansen; X Wu; L J Abraham; M Giphart; R L Dawkins
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

8.  Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM.

Authors:  M A Degli-Esposti; L J Abraham; V McCann; T Spies; F T Christiansen; R L Dawkins
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

9.  An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes.

Authors:  M A Degli-Esposti; A Andreas; F T Christiansen; B Schalke; E Albert; R L Dawkins
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

10.  Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.

Authors:  Riitta Paakkanen; Hanna Vauhkonen; Katja T Eronen; Asko Järvinen; Mikko Seppänen; Marja-Liisa Lokki
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.